single‐cell cytokine analysis allows detection of cervical T‐cell responses against human papillomavirus type 16 L1 in women infected with genital HPV
- 3 April 2002
- journal article
- research article
- Published by Wiley in Journal of Medical Virology
- Vol. 67 (2), 234-240
- https://doi.org/10.1002/jmv.2212
Abstract
Specific types of human papillomavirus (HPV) are known to play a causal role in the development of cervical cancer, with human papillomavirus type 16 (HPV‐16) identified as the predominant type. Despite this, little is known about cervical immune responses to this pathogen. The aim of this study was to assess the feasibility of cervical cytobrush sampling and single‐cell cytokine staining to investigate cervical lymphocyte‐specific cytokine responses to HPV‐16 antigens. Of eighteen women recruited into the study, five were HPV DNA positive at the cervix (current exposure) and a further five had circulating antibodies to HPV‐16 (previous exposure). Cervical lymphocytes, isolated from the five HPV DNA‐positive women, two HPV DNA‐negative controls, and one woman with circulating HPV‐16 antibodies were assessed for HPV‐specific responses using intracellular staining for interferon‐γ (IFN‐γ) and interleukin‐4 (IL‐4). We demonstrate that both CD4+ and CD8+ cervical T lymphocytes, harvested from noninfected and infected subjects, produce these cytokines in response to nonspecific stimulation. However, antigen‐specific (HPV‐16 L1) IFN‐γ production by CD4+ and CD8+ cervical T lymphocytes is only detectable in women exposed currently or previously to HPV‐16. This is the first time that antigen‐specific cytokine responses of mucosal lymphocytes, obtained from a site of HPV infection, have been demonstrated. This finding clearly illustrates the use of intracellular cytokine staining for investigation of low precursor frequency single‐cell antigen‐specific responses in lymphocytes harvested from mucosal sites with HPV infection. J. Med. Virol. 67:234–240, 2002.This publication has 31 references indexed in Scilit:
- Oral antibodies to human papillomavirus type 16 in women with cervical neoplasiaJournal of Medical Virology, 2001
- Cell-Mediated Immune Response to Human Papillomavirus InfectionClinical and Diagnostic Laboratory Immunology, 2001
- Mucosal Immunity in the Human Female Reproductive Tract: Cytotoxic T Lymphocyte Function in the Cervix and Vagina of Premenopausal and Postmenopausal WomenAmerican Journal of Reproductive Immunology, 1997
- Proliferative T cell responses to human papillomavirus type 16 L1 peptides in patients with cervical dysplasiaJournal of General Virology, 1996
- Normal Uterine Cervix: Characterization of Isolated Lymphocyte Phenotypes and Immunoglobulin SecretionAmerican Journal of Reproductive Immunology, 1995
- Prevalence of Human Papillomavirus in Cervical Cancer: a Worldwide PerspectiveJNCI Journal of the National Cancer Institute, 1995
- Typing of human papillomaviruses in cervical carcinoma biopsies from Cape TownJournal of Medical Virology, 1994
- Expression and gene transcript of Fc receptors for IgG, HLA class II antigens and Langerhans cells in human cervico-vaginal epitheliumClinical and Experimental Immunology, 1992
- Immunocytochemical characterization of large granular lymphocytes in normal cervix and HPV associated diseaseThe Journal of Pathology, 1991
- Clinical PhysicsScandinavian Journal of Clinical and Laboratory Investigation, 1968